More than four million people in France live with asthma [1].

These figures highlight a significant public health challenge in France, where the chronic condition continues to be under-recognized despite its impact on mortality and emergency care.

Data indicates that asthma causes approximately 60,000 hospitalizations each year [2]. The severity of the condition is further evidenced by the fact that about 1,000 people die from the disease annually [3].

Children are particularly vulnerable to the respiratory condition. Between 14% and 16% of French children are affected by asthma [4].

The prevalence of the disease across different age groups suggests a widespread need for better diagnostic tools, and patient management. While the number of deaths remains significant, the high rate of hospitalizations indicates that many patients experience acute crises that require urgent medical intervention.

Medical professionals said that the disease is often underestimated. This lack of recognition can lead to delayed treatment or improper management of the condition, contributing to the annual death toll and the strain on the healthcare system.

More than 4 million people in France live with asthma

The gap between the high number of asthma cases and the level of public and medical recognition suggests a systemic failure in early diagnosis and chronic care management in France. With a significant percentage of the pediatric population affected, the long-term burden on the French healthcare system will likely increase unless preventative strategies and awareness campaigns are scaled to match the prevalence of the disease.